Improving management of type 2 diabetes mellitus: 4. Meglitinides

Hosp Pract (1995). 1999 Dec 15;34(13):38-40. doi: 10.1080/21548331.1999.11443957.
No abstract available

MeSH terms

  • Carbamates / adverse effects
  • Carbamates / therapeutic use*
  • Contraindications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Piperidines / adverse effects
  • Piperidines / therapeutic use*

Substances

  • Carbamates
  • Hypoglycemic Agents
  • Piperidines
  • repaglinide